$240.330
+4.662 (+1.94%)At close
RMD News
RMD Events
Stock Futures Mixed as Doximity Soars 83.93%
Stock futures were mixed following a mostly lower regular session as investors continue to digest another round of corporate earnings and await news out of the Middle East.Economic data remains a central focus ahead of Friday's July employment report. Markets remain divided over the Federal Reserve's next policy move, with incoming employment data expected to play an important role in shaping expectations for interest rates over the coming months.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Doximityup 83.93%Atlassianup 32.1%Figsup 24.6%QuinStreetup 23%Cloudflareup 16.9%Twilioup 16.7%Nateraup 15.3%Akamaiup 13%Airbnbup 10.3%Instacartup 9%ALSO HIGHER -DoubleVerifyup 13.2% after Nielsen agreed to acquire the company in an all-cash transaction valued at roughly $2.15BDOWN AFTER EARNINGS -Trade Deskdown 24.5%QuidelOrthodown 21.8%Xponential Fitnessdown 12.9%Cable Onedown 9.5%Maravai Lifesciencesdown 8.8%ResMeddown 5.9%10x Genomicsdown 4.7%Dropboxdown 4.1%Post Holdingsdown 3%
Resmed Reports Q4 Revenue of $1.46B
Reports Q4 revenue $1.46B, consensus $1.46B. "We closed fiscal year 2026 with strong fourth quarter results, reflecting continued momentum of our global business, sustained demand for our market-leading products, and disciplined execution of our strategy," said Resmed's Chairman and CEO, Mick Farrell.
ResMed Increases Quarterly Dividend by 10% to 66 Cents
ResMed increases quarterly dividend 10% to 66c per quarter
Frazier Healthcare Partners to Acquire MatrixCare
Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, announced it has entered into a definitive agreement to acquire MatrixCare from ResMed. "Frazier has spent several years evaluating the post-acute care technology sector and believes MatrixCare has established itself as a leading platform serving skilled nursing, senior living, and home health and hospice providers," said Ryan Lucero, General Partner at Frazier Healthcare Partners. "We are thrilled to partner with the MatrixCare team and plan to invest aggressively in product innovation to help providers deliver better outcomes as the post-acute care landscape continues to evolve," added Clarissa Berman, Principal at Frazier Healthcare Partners. The proposed transaction, which is subject to customary closing conditions, is expected to be completed during the third quarter of 2026.
Resmed Sells MatrixCare Business to Frazier Healthcare Partners
Resmed announced it has entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners. The transaction includes MatrixCare and related software offerings historically sold under the MatrixCare brand, including Healthcare First, Citus and home health and hospice solutions. It excludes Resmed's other software businesses, Brightree in the U.S. and Medifox Dan in Germany. The transaction is expected to close during the first quarter of Resmed's fiscal year 2027, subject to required regulatory approvals and customary closing conditions. Until closing, MatrixCare will continue to operate as part of Resmed, with no changes to customer service or support.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.